Personal tools

Coexpression cluster:C2572: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
(Created page with "{{Coexpression_clusters |full_id=C2572_NK_chronic_embryonic_lymphoma_epithelioid_acute_adult |id=C2572 }}")
 
No edit summary
Line 2: Line 2:
|full_id=C2572_NK_chronic_embryonic_lymphoma_epithelioid_acute_adult
|full_id=C2572_NK_chronic_embryonic_lymphoma_epithelioid_acute_adult
|id=C2572
|id=C2572
|ontology_enrichment_celltype=CL:0000037!8.62e-49!172;CL:0000566!8.62e-49!172;CL:0000988!3.07e-46!182;CL:0002032!1.43e-45!165;CL:0000837!1.43e-45!165;CL:0000738!7.68e-32!140;CL:0002031!1.50e-29!124;CL:0002087!2.81e-28!119;CL:0000763!2.69e-24!112;CL:0000049!2.69e-24!112;CL:0000542!8.91e-20!53;CL:0000051!8.91e-20!53;CL:0000838!4.11e-19!52;CL:0000084!5.75e-13!25;CL:0000827!5.75e-13!25;CL:0000839!2.57e-12!70;CL:0000766!1.06e-11!76;CL:0000860!2.21e-11!45;CL:0000557!3.54e-11!71;CL:0000134!3.81e-10!358;CL:0000219!4.70e-10!390;CL:0002194!8.39e-10!63;CL:0000576!8.39e-10!63;CL:0000040!8.39e-10!63;CL:0000559!8.39e-10!63;CL:0002057!8.57e-10!42;CL:0002320!1.77e-09!365;CL:0000791!3.50e-09!18;CL:0000789!3.50e-09!18;CL:0002420!3.50e-09!18;CL:0002419!3.50e-09!18;CL:0000790!3.50e-09!18;CL:0002009!4.13e-09!65
|ontology_enrichment_disease=DOID:2531!2.38e-25!51;DOID:0060083!2.38e-25!51;DOID:1240!4.00e-22!39;DOID:8692!7.87e-16!31;DOID:162!1.43e-08!235;DOID:1036!4.38e-08!8;DOID:14566!7.58e-08!239;DOID:0050686!1.07e-07!137;DOID:0060058!3.92e-07!10
|ontology_enrichment_uberon=UBERON:0002390!1.47e-13!102;UBERON:0003061!1.47e-13!102;UBERON:0002193!3.07e-11!112;UBERON:0002384!1.10e-09!375;UBERON:0001474!1.80e-09!86;UBERON:0002371!1.84e-09!80;UBERON:0004765!3.78e-08!101;UBERON:0001434!3.78e-08!101;UBERON:0002405!9.36e-08!115
}}
}}

Revision as of 14:25, 21 May 2012


Full id: C2572_NK_chronic_embryonic_lymphoma_epithelioid_acute_adult



Phase1 CAGE Peaks

Hg19::chr1:226613592..226613598,-p@chr1:226613592..226613598
-
Hg19::chr2:26139327..26139333,+p@chr2:26139327..26139333
+
Hg19::chr6:2940610..2940615,+p@chr6:2940610..2940615
+
Hg19::chr6:3028692..3028697,+p@chr6:3028692..3028697
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Cell Type
Ontology termp-valuen
hematopoietic stem cell8.62e-49172
angioblastic mesenchymal cell8.62e-49172
hematopoietic cell3.07e-46182
hematopoietic oligopotent progenitor cell1.43e-45165
hematopoietic multipotent progenitor cell1.43e-45165
leukocyte7.68e-32140
hematopoietic lineage restricted progenitor cell1.50e-29124
nongranular leukocyte2.81e-28119
myeloid cell2.69e-24112
common myeloid progenitor2.69e-24112
lymphocyte8.91e-2053
common lymphoid progenitor8.91e-2053
lymphoid lineage restricted progenitor cell4.11e-1952
T cell5.75e-1325
pro-T cell5.75e-1325
myeloid lineage restricted progenitor cell2.57e-1270
myeloid leukocyte1.06e-1176
classical monocyte2.21e-1145
granulocyte monocyte progenitor cell3.54e-1171
mesenchymal cell3.81e-10358
motile cell4.70e-10390
monopoietic cell8.39e-1063
monocyte8.39e-1063
monoblast8.39e-1063
promonocyte8.39e-1063
CD14-positive, CD16-negative classical monocyte8.57e-1042
connective tissue cell1.77e-09365
mature alpha-beta T cell3.50e-0918
alpha-beta T cell3.50e-0918
immature T cell3.50e-0918
mature T cell3.50e-0918
immature alpha-beta T cell3.50e-0918
macrophage dendritic cell progenitor4.13e-0965
Uber Anatomy
Ontology termp-valuen
hematopoietic system1.47e-13102
blood island1.47e-13102
hemolymphoid system3.07e-11112
connective tissue1.10e-09375
bone element1.80e-0986
bone marrow1.84e-0980
skeletal element3.78e-08101
skeletal system3.78e-08101
immune system9.36e-08115
Disease
Ontology termp-valuen
hematologic cancer2.38e-2551
immune system cancer2.38e-2551
leukemia4.00e-2239
myeloid leukemia7.87e-1631
cancer1.43e-08235
chronic leukemia4.38e-088
disease of cellular proliferation7.58e-08239
organ system cancer1.07e-07137
lymphoma3.92e-0710


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.